Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Mar;2(2):138–142. doi: 10.1128/cdli.2.2.138-142.1995

Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection.

J Ferbas 1, J Navratil 1, A Logar 1, C Rinaldo 1
PMCID: PMC170116  PMID: 7697520

Abstract

We previously reported that human immunodeficiency virus type 1 (HIV-1), herpes simplex virus (HSV), and Sendai virus induce higher levels of alpha interferon (IFN-alpha) in blood dendritic cells than in monocytes of healthy donors. In the present study, the levels of IFN-alpha induced by T-cell tropic (IIIb and RF) and monocytotropic (BaL) strains of HIV-1 and by HSV were significantly decreased in peripheral blood mononuclear cells (PBMCs) derived from subjects with asymptomatic and symptomatic HIV-1 infection. In contrast, Sendai virus, a paramyxovirus that induces proportionally more IFN-alpha in monocytes and B cells than do either HIV-1 or HSV, stimulated normal levels of IFN-alpha in PBMCs from the HIV-1-infected men. The IFN-alpha produced by PBMCs from the HIV-1-seropositive subjects was partially acid labile, whereas the IFN-alpha produced by PBMCs from the HIV-1-seronegative donors was acid stable. We hypothesize that there is a selective defect in IFN-alpha production by peripheral blood dendritic cells, whereas the host retains the IFN-alpha-producing capacity of monocytes and B lymphocytes. The loss of IFN-alpha production in response to HIV-1, herpesviruses, and possibly other pathogens could contribute to the progression of HIV-1 infection and to the development of AIDS.

Full Text

The Full Text of this article is available as a PDF (211.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abb J., Zachoval R., Zachoval V., Deinhardt F. HIV antigen, HIV antibody and serum interferon in a patient with encephalopathy. Infection. 1987 Nov-Dec;15(6):425–426. doi: 10.1007/BF01647221. [DOI] [PubMed] [Google Scholar]
  2. Brinkmann V., Geiger T., Alkan S., Heusser C. H. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993 Nov 1;178(5):1655–1663. doi: 10.1084/jem.178.5.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Capobianchi M. R., De Marco F., Di Marco P., Dianzani F. Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells. Arch Virol. 1988;99(1-2):9–19. doi: 10.1007/BF01311019. [DOI] [PubMed] [Google Scholar]
  4. Capobianchi M. R., Mattana P., Mercuri F., Conciatori G., Ameglio F., Ankel H., Dianzani F. Acid lability is not an intrinsic property of interferon-alpha induced by HIV-infected cells. J Interferon Res. 1992 Dec;12(6):431–438. doi: 10.1089/jir.1992.12.431. [DOI] [PubMed] [Google Scholar]
  5. Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993 Mar;91(3):759–765. doi: 10.1172/JCI116294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeStefano E., Friedman R. M., Friedman-Kien A. E., Goedert J. J., Henriksen D., Preble O. T., Sonnabend J. A., Vilcek J. Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis. 1982 Oct;146(4):451–459. doi: 10.1093/infdis/146.4.451. [DOI] [PubMed] [Google Scholar]
  7. Eyster M. E., Goedert J. J., Poon M. C., Preble O. T. Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N Engl J Med. 1983 Sep 8;309(10):583–586. doi: 10.1056/NEJM198309083091003. [DOI] [PubMed] [Google Scholar]
  8. Ferbas J. J., Toso J. F., Logar A. J., Navratil J. S., Rinaldo C. R., Jr CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol. 1994 May 1;152(9):4649–4662. [PubMed] [Google Scholar]
  9. Fitzgerald-Bocarsly P. Human natural interferon-alpha producing cells. Pharmacol Ther. 1993 Oct;60(1):39–62. doi: 10.1016/0163-7258(93)90021-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Francis M. L., Meltzer M. S. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J Immunol. 1993 Aug 15;151(4):2208–2216. [PubMed] [Google Scholar]
  11. Gendelman H. E., Friedman R. M., Joe S., Baca L. M., Turpin J. A., Dveksler G., Meltzer M. S., Dieffenbach C. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med. 1990 Nov 1;172(5):1433–1442. doi: 10.1084/jem.172.5.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grage-Griebenow E., Lorenzen D., Fetting R., Flad H. D., Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol. 1993 Dec;23(12):3126–3135. doi: 10.1002/eji.1830231213. [DOI] [PubMed] [Google Scholar]
  13. Graziosi C., Pantaleo G., Gantt K. R., Fortin J. P., Demarest J. F., Cohen O. J., Sékaly R. P., Fauci A. S. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 1994 Jul 8;265(5169):248–252. doi: 10.1126/science.8023143. [DOI] [PubMed] [Google Scholar]
  14. Gupta P., Balachandran R., Grovit K., Webster D., Rinaldo C., Jr Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay. J Clin Microbiol. 1987 Jun;25(6):1122–1125. doi: 10.1128/jcm.25.6.1122-1125.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holán V., Kohno K., Minowada J. Natural human interferon-alpha augments interleukin-2 production by a direct action on the activated IL-2-producing T cells. J Interferon Res. 1991 Dec;11(6):319–325. doi: 10.1089/jir.1991.11.319. [DOI] [PubMed] [Google Scholar]
  16. Howell D. M., Feldman S. B., Kloser P., Fitzgerald-Bocarsly P. Decreased frequency of functional natural interferon-producing cells in peripheral blood of patients with the acquired immune deficiency syndrome. Clin Immunol Immunopathol. 1994 May;71(2):223–230. doi: 10.1006/clin.1994.1076. [DOI] [PubMed] [Google Scholar]
  17. Kaslow R. A., Ostrow D. G., Detels R., Phair J. P., Polk B. F., Rinaldo C. R., Jr The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987 Aug;126(2):310–318. doi: 10.1093/aje/126.2.310. [DOI] [PubMed] [Google Scholar]
  18. Lane H. C., Kovacs J. A., Feinberg J., Herpin B., Davey V., Walker R., Deyton L., Metcalf J. A., Baseler M., Salzman N. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet. 1988 Nov 26;2(8622):1218–1222. doi: 10.1016/s0140-6736(88)90811-2. [DOI] [PubMed] [Google Scholar]
  19. Lopez C., Fitzgerald P. A., Siegal F. P. Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections. J Infect Dis. 1983 Dec;148(6):962–966. doi: 10.1093/infdis/148.6.962. [DOI] [PubMed] [Google Scholar]
  20. Macatonia S. E., Hsieh C. S., Murphy K. M., O'Garra A. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol. 1993 Sep;5(9):1119–1128. doi: 10.1093/intimm/5.9.1119. [DOI] [PubMed] [Google Scholar]
  21. Matsuoka H., Kakui Y., Tanaka A., Cho Y., Imanishi J. Acid-labile interferon produced in human peripheral leukocytes by induction with Sendai virus. J Gen Virol. 1985 Nov;66(Pt 11):2491–2494. doi: 10.1099/0022-1317-66-11-2491. [DOI] [PubMed] [Google Scholar]
  22. Mehta-Damani A., Markowicz S., Engleman E. G. Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol. 1994 Aug 1;153(3):996–1003. [PubMed] [Google Scholar]
  23. Moskophidis D., Lechner F., Pircher H., Zinkernagel R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 1993 Apr 22;362(6422):758–761. doi: 10.1038/362758a0. [DOI] [PubMed] [Google Scholar]
  24. Murray H. W., Scavuzzo D. A., Kelly C. D., Rubin B. Y., Roberts R. B. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch Intern Med. 1988 Jul;148(7):1613–1616. [PubMed] [Google Scholar]
  25. Müller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 1994 Jun 24;264(5167):1918–1921. doi: 10.1126/science.8009221. [DOI] [PubMed] [Google Scholar]
  26. O'Doherty U., Peng M., Gezelter S., Swiggard W. J., Betjes M., Bhardwaj N., Steinman R. M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 1994 Jul;82(3):487–493. [PMC free article] [PubMed] [Google Scholar]
  28. Patterson S., Gross J., Bedford P., Knight S. C. Morphology and phenotype of dendritic cells from peripheral blood and their productive and non-productive infection with human immunodeficiency virus type 1. Immunology. 1991 Mar;72(3):361–367. [PMC free article] [PubMed] [Google Scholar]
  29. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Annu Rev Biochem. 1987;56:727–777. doi: 10.1146/annurev.bi.56.070187.003455. [DOI] [PubMed] [Google Scholar]
  30. Pitha P. M. Multiple effects of interferon on HIV-1 replication. J Interferon Res. 1991 Dec;11(6):313–318. doi: 10.1089/jir.1991.11.313. [DOI] [PubMed] [Google Scholar]
  31. Rappocciolo G., Toso J. F., Torpey D. J., 3rd, Gupta P., Rinaldo C. R., Jr Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. J Clin Microbiol. 1989 Jan;27(1):41–48. doi: 10.1128/jcm.27.1.41-48.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rinaldo C., Piazza P., Wang Y. Z., Armstrong J., Gupta P., Ho M., Petteway S., Reed D., Lyter D., Kingsley L. HIV-1-specific production of IFN-gamma and modulation by recombinant IL-2 during early HIV-1 infection. J Immunol. 1988 May 15;140(10):3389–3393. [PubMed] [Google Scholar]
  33. Rossol S., Voth R., Laubenstein H. P., Müller W. E., Schröder H. C., Meyer zum Büschenfelde K. H., Hess G. Interferon production in patients infected with HIV-1. J Infect Dis. 1989 May;159(5):815–821. doi: 10.1093/infdis/159.5.815. [DOI] [PubMed] [Google Scholar]
  34. Siegal F. P., Lopez C., Fitzgerald P. A., Shah K., Baron P., Leiderman I. Z., Imperato D., Landesman S. Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest. 1986 Jul;78(1):115–123. doi: 10.1172/JCI112539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271–296. doi: 10.1146/annurev.iy.09.040191.001415. [DOI] [PubMed] [Google Scholar]
  36. Stringfellow D. A. Interferon induction: hyporesponsiveness and prostaglandins. Tex Rep Biol Med. 1981;41:116–121. [PubMed] [Google Scholar]
  37. Thomas R., Davis L. S., Lipsky P. E. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol. 1993 Dec 15;151(12):6840–6852. [PubMed] [Google Scholar]
  38. Voth R., Rossol S., Klein K., Hess G., Schütt K. H., Schröder H. C., Meyer zum Büschenfelde K. H., Müller W. E. Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol. 1990 Feb 1;144(3):970–975. [PubMed] [Google Scholar]
  39. Yee A. M., Buyon J. P., Yip Y. K. Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile. J Exp Med. 1989 Mar 1;169(3):987–993. doi: 10.1084/jem.169.3.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. de Wit R., Schattenkerk J. K., Boucher C. A., Bakker P. J., Veenhof K. H., Danner S. A. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet. 1988 Nov 26;2(8622):1214–1217. doi: 10.1016/s0140-6736(88)90810-0. [DOI] [PubMed] [Google Scholar]
  41. von Sydow M., Sönnerborg A., Gaines H., Strannegård O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses. 1991 Apr;7(4):375–380. doi: 10.1089/aid.1991.7.375. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES